Danbury, Connecticut-based Biodel Inc. is a $62M market cap specialty biopharmaceutical company that focuses on the development and commercialization of diabetes treatments.
via Danbury Newswire http://seekingalpha.com/article/1704192-is-biodel-a-buy-or-sell?source=feed
via Danbury Newswire http://seekingalpha.com/article/1704192-is-biodel-a-buy-or-sell?source=feed
No comments:
Post a Comment